Evidence map›Paper›PMID 26424696›Full record

ArticleCancer research2015

Fluorophore-NanoLuc BRET Reporters Enable Sensitive In Vivo Optical Imaging and Flow Cytometry for Monitoring Tumorigenesis.

Franz X Schaub, Md Shamim Reza, Colin A Flaveny, Weimin Li, Adele M Musicant, Sany Hoxha, Min Guo, John L Cleveland, Antonio L Amelio

Open access · greenAbstract read
In one paragraph

Article in Cancer research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 71 papers.

0numbers the graph read from it
0cells of the map it votes in
71citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

71 citing papers in PubMed, 118 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Mycobacteriophage-mediated gene transfer enables in vitro drug screening and in vivo tracking ofProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. OptimizediScience · 2024
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

11 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Franz X SchaubDepartment of Tumor Biology, Moffitt Cancer Center and Research Institute, Tampa, Florida.
Md Shamim RezaDepartment of Cancer Biology, The Scripps Research Institute, Scripps Florida, Jupiter, Florida.
Colin A FlavenyDepartment of Pharmacological & Physiological Science, School of Medicine, Saint Louis University, St. Louis, Missouri.
Weimin LiDepartment of Tumor Biology, Moffitt Cancer Center and Research Institute, Tampa, Florida.
Adele M MusicantUNC Biological and Biomedical Sciences Graduate Program, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
Sany HoxhaScripps Graduate Program, The Scripps Research Institute, Scripps Florida, Jupiter, Florida.
Min GuoDepartment of Cancer Biology, The Scripps Research Institute, Scripps Florida, Jupiter, Florida.
John L ClevelandDepartment of Tumor Biology, Moffitt Cancer Center and Research Institute, Tampa, Florida.
Antonio L AmelioLineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina. Biomedical Research Imaging Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina. antonio_amelio@unc.edu.
University of North Carolina at Chapel Hill · US

Funding

Virology Research Program (Program 4)P30CA016086 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Deborah F. Tate · 1985 to 2026
$201.5M
TRANSLATIONAL RESEARCHP30CA076292 · NCI · UNIVERSITY OF SOUTH FLORIDA · PI KENNETH Lynn WRIGHT · 1998 to 2026
$93.5M
NRSA IN GENETICST32GM007092 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI SEKELSKY, JEFF J. · 1985 to 2019
$5.9M
Myc-directed control of mRNA turnover in lymphopoiesis and lymphomagenesisR01CA167093 · NCI · SCRIPPS FLORIDA · PI CLEVELAND, JOHN L. · 2012 to 2016
$1.9M
Structural and Functional Studies of LysRS in Mast Cell ActivationR01GM100136 · NIGMS · SCRIPPS FLORIDA · PI KODADEK, THOMAS J. · 2012 to 2016
$1.9M
HTS for Direct Targeting of the Transcription Factor MITFR01CA178315 · NCI · SCRIPPS FLORIDA · PI KODADEK, THOMAS J., SCAMPAVIA, LOUIS DANIEL · 2014 to 2016
$1.6M
Convergence of CREB and MYC Pathways in Oncogenesis.R00CA157954 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI AMELIO, ANTONIO LUIGI · 2014 to 2016
$740k
NCI NIH HHS P30 CA016086NCI NIH HHS P30-CA016806NCI NIH HHS P30 CA076292NCI NIH HHS P30-CA076292NCI NIH HHS R00 CA157954NCI NIH HHS R00-CA157954NCI NIH HHS R01 CA167093NCI NIH HHS R01 CA178315NIGMS NIH HHS R01 GM100136NIGMS NIH HHS T32 GM007092
6 · The paper itself

Abstract

Fluorescent proteins are widely used to study molecular and cellular events, yet this traditionally relies on delivery of excitation light, which can trigger autofluorescence, photoxicity, and photobleaching, impairing their use in vivo. Accordingly, chemiluminescent light sources such as those generated by luciferases have emerged, as they do not require excitation light. However, current luciferase reporters lack the brightness needed to visualize events in deep tissues. We report the creation of chimeric eGFP-NanoLuc (GpNLuc) and LSSmOrange-NanoLuc (OgNLuc) fusion reporter proteins coined LumiFluors, which combine the benefits of eGFP or LSSmOrange fluorescent proteins with the bright, glow-type bioluminescent light generated by an enhanced small luciferase subunit (NanoLuc) of the deep-sea shrimp Oplophorus gracilirostris. The intramolecular bioluminescence resonance energy transfer that occurs between NanoLuc and the fused fluorophore generates the brightest bioluminescent signal known to date, including improved intensity, sensitivity, and durable spectral properties, thereby dramatically reducing image acquisition times and permitting highly sensitive in vivo imaging. Notably, the self-illuminating and bifunctional nature of these LumiFluor reporters enables greatly improved spatiotemporal monitoring of very small numbers of tumor cells via in vivo optical imaging and also allows the isolation and analyses of single cells by flow cytometry. Thus, LumiFluor reporters are inexpensive, robust, noninvasive tools that allow for markedly improved in vivo optical imaging of tumorigenic processes.

Indexed as

AnimalsBurkitt LymphomaCarcinogenesisCarcinoma, Non-Small-Cell LungDecapodaFlow CytometryGreen Fluorescent ProteinsHEK293 CellsHeterograftsHumansLuciferasesLuminescent AgentsLung NeoplasmsMice, Inbred NODMice, SCIDOptical Imagingenhanced green fluorescent proteinGreen Fluorescent ProteinsLuciferasesLuminescent AgentsRecombinant Fusion Proteins

Identifiers

PMID26424696
PMCPMC4668208
OpenAlexW2177259138

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.